Follow
Andrew Erickson
Title
Cited by
Cited by
Year
PTEN loss but not ERG expression in diagnostic biopsies is associated with increased risk of progression and adverse surgical findings in men with prostate cancer on active …
U Lokman, AM Erickson, H Vasarainen, AS Rannikko, T Mirtti
European urology focus 4 (6), 867-873, 2018
482018
Loss of PTEN expression in ERG-negative prostate cancer predicts secondary therapies and leads to shorter disease-specific survival time after radical prostatectomy
K Lahdensuo, A Erickson, I Saarinen, H Seikkula, J Lundin, M Lundin, ...
Modern Pathology 29 (12), 1565-1574, 2016
472016
Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse
S Taavitsainen, N Engedal, S Cao, F Handle, A Erickson, S Prekovic, ...
Nature communications 12 (1), 1-16, 2021
242021
Fibroblast as a critical stromal cell type determining prognosis in prostate cancer
S Blom, A Erickson, A Östman, A Rannikko, T Mirtti, O Kallioniemi, ...
The Prostate 79 (13), 1505-1513, 2019
242019
New prostate cancer grade grouping system predicts survival after radical prostatectomy
A Erickson, K Sandeman, K Lahdensuo, S Nordling, M Kallajoki, ...
Human pathology 75, 159-166, 2018
222018
Repeat multiparametric MRI in prostate cancer patients on active surveillance
JT Eineluoto, P Järvinen, A Kenttämies, TP Kilpeläinen, H Vasarainen, ...
PloS one 12 (12), e0189272, 2017
222017
Increased HSF1 expression predicts shorter disease-specific survival of prostate cancer patients following radical prostatectomy
JK Björk, I Ahonen, T Mirtti, A Erickson, A Rannikko, A Bützow, S Nordling, ...
Oncotarget 9 (58), 31200, 2018
212018
Increase of prostate biopsy-related bacteremic complications in southern Finland, 2005–2013: a population-based analysis
K Lahdensuo, A Rannikko, VJ Anttila, A Erickson, A Pätäri-Sampo, ...
Prostate cancer and prostatic diseases 19 (4), 417-422, 2016
162016
Enzalutamide-Induced Feed-Forward Signaling Loop Promotes Therapy-Resistant Prostate Cancer Growth Providing an Exploitable Molecular Target for Jak2 InhibitorsJak2-Stat5 and …
V Udhane, C Maranto, DT Hoang, L Gu, A Erickson, S Devi, PG Talati, ...
Molecular cancer therapeutics 19 (1), 231-246, 2020
142020
Spatially resolved clonal copy number alterations in benign and malignant tissue
A Erickson, M He, E Berglund, M Marklund, R Mirzazadeh, N Schultz, ...
Nature 608 (7922), 360, 2022
102022
Morphological Features Extracted by AI Associated with Spatial Transcriptomics in Prostate Cancer
E Chelebian, C Avenel, K Kartasalo, M Marklund, A Tanoglidi, T Mirtti, ...
Cancers 13 (19), 4837, 2021
102021
Positive STAT5 Protein and Locus Amplification Status Predicts Recurrence after Radical Prostatectomy to Assist Clinical Precision Management of Prostate CancerSTAT5 Status and …
BR Haddad, A Erickson, V Udhane, PS LaViolette, JD Rone, MA Kallajoki, ...
Cancer Epidemiology, Biomarkers & Prevention 28 (10), 1642-1651, 2019
102019
The spatial landscape of clonal somatic mutations in benign and malignant tissue
A Erickson, E Berglund, M He, M Marklund, R Mirzazadeh, N Schultz, ...
bioRxiv, 2021
92021
A systematic review of prostate cancer heterogeneity: Understanding the clonal ancestry of multifocal disease
A Erickson, A Hayes, T Rajakumar, C Verrill, RJ Bryant, FC Hamdy, ...
European urology oncology 4 (3), 358-369, 2021
62021
Ductal adenocarcinoma of the prostate: a systematic review and meta‐analysis of incidence, presentation, prognosis, and management
N Ranasinha, A Omer, Y Philippou, E Harriss, L Davies, K Chow, ...
BJUI compass 2 (1), 13-23, 2021
62021
Prostate MRI added to CAPRA, MSKCC and Partin cancer nomograms significantly enhances the prediction of adverse findings and biochemical recurrence after radical prostatectomy
K Sandeman, JT Eineluoto, J Pohjonen, A Erickson, TP Kilpeläinen, ...
Plos one 15 (7), e0235779, 2020
62020
Grading Evolution and Contemporary Prognostic Biomarkers of Clinically Significant Prostate Cancer
K Sopyllo, AM Erickson, T Mirtti
Cancers 13 (4), 628, 2021
52021
274 Prostate cancer active surveillance: Health-related quality of life in the Finnish arm of the prospective PRIAS-study. Three year update
U Lokman, H Vasarainen, K Lahdensuo, AM Erickson, K Taari, TK Mirtti, ...
European Urology Supplements 1 (12), e274-e275, 2013
52013
Cumulative Cancer Locations is a Novel Metric for Predicting Active Surveillance Outcomes: A Multicenter Study
AM Erickson, S Luzzago, A Semjonow, H Vasarainen, TD Laajala, G Musi, ...
European Urology Oncology 1 (4), 268-275, 2018
42018
Multiplex immunohistochemical phenotyping of T cells in primary prostate cancer
B Ozbek, O Ertunc, A Erickson, ID Vidal, C Gomes‐Alexandre, G Guner, ...
The Prostate 82 (6), 706-722, 2022
32022
The system can't perform the operation now. Try again later.
Articles 1–20